Loeb & Loeb LLP is a sponsor of iiBIG's "Pharmaceutical & Biotech OUTSOURCING” conference.
From the conference brochure:
The need to “feed the pipeline beast” has driven phenomenal growth in the outsourcing business. And one of the fastest growing areas of this business has been occurring in early stage discovery – through and including - investigational new drug application (IND). iiBIG’s “Pharmaceutical & Biotech OUTSOURCING” conference focuses exclusively on the issues unique to these early stages.
This conference is all about real world examples and practical tips. Each day begins with a comprehensive overview session, and then splits into two tracks:
- TRACK A covers the Stages of Development – from early Molecule Screening to Phase I Clinical Trials. Each of our sessions in TRACK A will include ‘real world’ case studies that drill down into specific issues unique to early stage outsourcing of chemistry, pharmacology, toxicology, ADME, formulation and more. For those who want to focus process issues.
- TRACK B covers the Process of Outsourcing – practical tips and real world examples on how to insure that outsourcing partnerships run smoothly. TRACK B will provide valuable information and useful tips regarding things like negotiating the agreement, managing the relationship, protecting intellectual property rights, and the unique factors to consider when working across cultures.
Agenda Highlight for Track B - The Process of Outsourcing
Wednesday, July 11, 11:30 AM
Loeb Partner Ira Schreger will present "Intellectual Property Considerations."